@drmarthagulati.bsky.social on Bluesky

JavaScript RequiredThis is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is. Learn more about Bluesky at bsky.social and atproto.com.

Post

Dr Martha Gulati

drmarthagulati.bsky.social

did:plc:wo5qahyb3qa2qekcxaflkdq3

Dr. Nissen presents #ALPACA assessing siRNA in ⬇️ Lp(a) Lepodisiran ♥️400 mg dose: 95% ⬇️, sustained 180 days but still effects after at 540 days ♥️ Large ⬇️ in Lp(a) ♥️ ApoB ⬇️ by 15% ♥️ safety favorable: 1 withdrew in placebo #ACC25 #CVPrev @nejm.org 📎 https://www.nejm.org/doi/full/10.1056/NEJMoa2415818?utm_source=conf&utm_medium=qr&utm_campaign=ACC2025

2025-03-30T23:35:43.805Z